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Abstract
Objectives Contrast media (CM) extravasation is a well-
known complication of CT angiography (CTA). Our prospec-
tive randomized control study aimed to assess whether a four-
phasic CM administration protocol reduces the risk of extrav-
asation compared to the routinely used three-phasic protocol
in coronary CTA.
Methods Patients referred to coronary CTA due to suspected
coronary artery disease were included in the study. All patients
received 400 mg/ml iomeprol CM injected with dual-syringe
automated injector. Patients were randomized into a three-
phasic injection-protocol group, with a CM bolus of 85 ml
followed by 40 ml of 75%:25% saline/CM mixture and
30ml saline chaser bolus; and a four-phasic injection-protocol
group, with a saline pacer bolus of 10 ml injected at a lower
flow rate before the three-phasic protocol.
Results 2,445 consecutive patients were enrolled (mean age
60.6 ± 12.1 years; females 43.6%). Overall rate of extravasa-
tion was 0.9% (23/2,445): 1.4% (17/1,229) in the three-phasic
group and 0.5% (6/1,216) in the four-phasic group (p =
0.034).
Conclusions Four-phasic CM administration protocol is easy
to implement in the clinical routine at no extra cost. The ex-
travasation rate is reduced by 65% with the application of the
four-phasic protocol compared to the three-phasic protocol in
coronary CTA.
Key Points
• Four-phasic CM injection-protocol reduces extravasation
rate by 65% compared to three-phasic.
• The saline pacer bolus substantially reduces the risk of CM
extravasation.
• The implementation of four-phasic injection-protocol is at no
cost.
Keywords Computed tomography angiography . Contrast
media . Contrast media extravasation .Multidetector-row
computed tomography . Coronary heart disease
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Introduction
To achieve robust diagnostic performance in coronary com-
puted tomography angiography (CTA) adequate intraluminal
iodinated contrast media (CM) concentration is required.
Therefore, high flow rate injection, high concentration and
relatively large volume of CM is used in daily practice.
However, the highly viscous iodinated CM and the high in-
jection flow rate increase the risk of vessel wall injury
resulting in CM extravasation.
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Contrast media extravasation is a well-known complication
of CTA, with an incidence rate of 0.3–1.3% [1–6]. In case of
CM extravasation, image quality is deteriorated due to insuf-
ficient intraluminal attenuation [7, 8], leading to an increased
number of repeated CTA examinations, which results in extra
radiation doses, additional CM load and increased costs.
Extravasation usually resolves without any serious complica-
tions; however, in some instances it can lead to severe injuries
[9]. CM has toxic effects on perivascular tissues that may
trigger acute and chronic local inflammatory response, tissue
necrosis or compartment syndrome [4, 5, 10, 11]. It has been
shown that female gender, elderly age, history of chemo- or
radiotherapy, lowmuscle volume and peripheral locations oth-
er than the cubital region as injection site increase the risk of
CM extravasation [2, 3, 12].
A three-phasic CM injection-protocol is widely used to
achieve optimal attenuation during coronary CTA, which re-
sults in high contrast enhancement in the left side of the heart
and in a lower enhancement in the right [13, 14]. The tradi-
tional three-phasic injection-protocol starts with a high flow
rate CM injection (>5 ml/s), continues with a mixture of CM
and saline, and finishes with a saline chaser bolus.We hypoth-
esized that the relatively large quantity of high viscosity CM
could place an increased strain on the vein’s wall, which in-
creases the risk of extravasation. Extending the three-phasic
injection-protocol with an initial slower saline flux of pacer
bolus right before CM administration may open the possibly
collapsed vein lumen with less stress on the vessel wall, thus
when the contrast material enters the lumen with a higher flow
rate, the already pre-dilated lumen is less likely to rupture.
Therefore, we sought to evaluate the effect of a four-phasic
contrast injection-protocol on the CM extravasation rate in
coronary CTA in a randomized controlled clinical trial.
Materials and methods
Study design
In this prospective, single-centre, single-blinded, randomized,
controlled clinical trial we compared two contrast media
injection-protocols in patients who were referred for coronary
CTA examination. We randomized patients into two groups:
(1) a three-phasic injection-protocol group and (2) a four-
phasic injection-protocol group. To achieve randomization,
we alternated the use of three-phasic and four-phasic CM ad-
ministration protocols on a weekly basis: on even weeks, we
applied the three-phasic protocol, and on odd weeks we used
the four-phasic protocol. The primary endpoint was the occur-
rence of CM extravasation. CM extravasation was defined as
(1) presence of pain and local swelling close to the cannula
insertion site occurring after the initiation of CM injection, and
(2) absence of CM or minimal CM attenuation in cardiac
chambers on the CTA images. Our institutional review board
approved the study and informed consent was waived.
Study population and CTA protocol
We included consecutive patients who were referred for cor-
onary CTA from January 2014 to August 2015. Exclusion
criteria were contraindications to iodinated CM, age under
18 years and the presence of a cannula that was not inserted
by our radiographers.
We performed all coronary CTA examinations with a 256-
slice multi-detector row CT scanner (Brilliance iCT 256;
Philips Healthcare, Best, The Netherlands). Contrast-
enhanced image acquisition was performed in inspiration dur-
ing a single breath-hold in a cranio-caudal direction. The fol-
lowing imaging parameters were used: slice collimation of
128 mm× 0.625 mm, rotation time of 270 ms, tube voltage
100–120 kVand tube current 150–300 mAs depending on the
patient’s weight. The majority of scans (99.8%) were acquired
by using prospective ECG triggering at 78% phase of the
cardiac cycle with 3% padding. Bolus tracking was used with
a region of interest (ROI) placed in the left atrium. Images
were reconstructed with a slice thickness of 0.8 mm and
0.4 mm increment.
Contrast media injection-protocol
All patients received the same type of cannula (B. Braun
Medical Inc., Melsungen, Germany). All cannulas were
inserted by certified radiographers. The preferred location of
vein puncture was the right antecubital region. Other distal
venous access locations were used if no suitable vein was
found in the antecubital region. We registered venipuncture
characteristics, such as the side and location of venous access,
the size of the inserted cannula and the number of insertion
attempts. In all patients the injection site was tested with a 20-
ml saline bolus. All patients received a 400 mg/ml concentra-
tion iomeprol (Iomeron 400, Bracco Spa, Milan, Italy) CM
injectedwith dual-syringe automatedmechanical injector. CM
was pre-heated to 37 °C. In patients havingmore than 80 kg of
bodyweight we used a 5.5 ml/s injection rate and 95 ml CM
and 120 kV tube voltage. In patients less than 80 kg in
bodyweight we used an injection rate of 4.5 ml/s, 80 ml CM
and 100 kV tube voltage.
In the three-phasic protocol group the injection started with
the CM bolus, followed by 40 ml of 75%:25% saline-CM
mixture, and finished with 30 ml of chaser saline bolus.
With the four-phasic protocol the injection started with the
saline pacer bolus of 10 ml, administered with 1.5 ml/s lower
flow rate than the CM bolus; specifically, a saline pacer bolus
flow rate of 4.0 ml/s if the injection rate of CM was 5.5 ml/s
and 3 ml/s if the CM flow rate was 4.5 ml/s and continued
with the steps of the three-phasic protocol (Fig. 1).
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Statistical analysis
Continuous variables are reported as mean ± standard devia-
tion. Based on our relatively large sample size the central limit
theorem allows the use of parametric tests, therefore we com-
pared the continuous variables using Student’s t-test. To eval-
uate the differences between categorical variables we used
Fisher’s exact test. Two-sided P values below 0.05 were con-
sidered statistically significant. For risk estimation, we calcu-
lated the odds ratio (OR) with 95% confidence intervals (CIs).
All statistical data analysis was performed with IBM SPSS
(IBM Corp: version 23, Armonk, NY, USA).
Results
In total, 2,445 consecutive patients with suspected coronary
artery disease were enrolled between 2014 January and 2015
August. The mean age was 60.6 ± 12.1 years and there were
less female patients than males (females 43.6%). The clinical
characteristics of included patients are summarized in Table 1.
Out of the 2,445 patients, 1,229 (50.3%) received a three-
phasic and 1,216 (49.7%) a four-phasic CM injection-protocol
(Table 2). The overall number of CM extravasation was 23 out
of 2,445 patients (0.9%). The CM extravasation rate in the
three-phasic group was 1.4% (17/1,229), whereas in the
four-phasic group the extravasation rate was 0.5% (6/1,216),
p = 0.034 (Fig. 2). The four-phasic CM injection-protocol re-
sulted in 65% reduction in extravasation rate as compared to
the three-phasic CM injection-protocol in coronary CTA
(odds ratio (OR): 0.354; CI: 0.139–0.900; p = 0.029). The
majority of the patients received an 18 G cannula for CM
injection (97.2% of all patients). The use of a 20 G cannula
did not differ between the two groups (three-phasic protocol
group 34 (3.1%), four-phasic protocol group 38 (3.1%), re-
spectively, p = 0.63).
Besides the CM injection-protocol none of the clinical and
vein quality characteristics of patients who had extravasation
versus patients with no extravasation showed any differences
(Table 2). In the four-phasic group a CM injection rate of
5.5 ml/s was administered in 88.4% (1,075/1,216) of the pa-
tients, which was lower than the three-phasic protocol group
(91.2%, 1,121/1,229), p = 0.02. Even though we found a sig-
nificant difference between the two groups, this did not influ-
ence extravasation rates, since there was no difference in in-
jection rates among patients with extravasation (5.5 ml/s flow
Fig. 1 Schematic representation of the three-phasic and the four-phasic
contrast media (CM) injection-protocols. The three-phasic protocol starts
with an undiluted CM bolus, followed by a 75%:25% saline and CM
mixture and ends with a 30-ml chaser saline bolus. The four-phasic
protocol starts with a 10-ml saline pacer bolus, administered at a
1.5 ml/s slower flow rate than the CM bolus, and continues with the
three-phasic protocol. The injection rate settings are dependent on the
body weight of the patient and on the tube voltage settings
Table 1 Clinical
characteristics of the
patients
n = 2445
Age (y) 60.6 ± 12.1
Female (%) 1,065 (43.6)
Height (cm) 171.2 ± 10.1
Weight (kg) 84.0 ± 17.2
BMI (kg/m2) 28.5 ± 4.8
Hypertension (%) 1,605 (65.6)
Diabetes (%) 393 (16.1)
Dyslipidaemia (%) 1,142 (46.7)
AMI (%) 185 (7.6)
PAD (%) 236 (9.7)
Stroke/TIA (%) 135 (5.5)
Current smoking (%) 990 (40.5)
Total DLP (mGy*cm) 356.8 ± 142.0
Effective dose (mSv) 5.0 ± 2.0
Contrast material (ml) 91.2 ± 7.3
AMI acute myocardial infarction, BMI
body mass index, PAD peripheral artery
disease, TIA transient ischaemic attack,
DLP dose-length product
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rate: 95.7% (22/23)) versus patients who had no extravasation
(5.5 ml/s flow rate: 89.8% (2,174/2,422)), p = 0.72.
We assessed the effect of the three- and four-phasic CM
injection protocols in subgroups considered prone to develop-
ing extravasation. Among females, less extravasation events
occurred in the four-phasic group compared to the three-
phasic group (5.6% (3/533) vs. 23.2% (12/517), respectively
p = 0.02). Similarly, we could detect significantly less extrav-
asation when the four-phasic protocol was administered to
patients older than 60 years compared to the three-phasic
group (4.0% (3/732) vs. 19.4% (14/720), respectively p =
0.007). Furthermore, we did not experience any extravasation
in patients who received a 20 G cannula.
Discussion
In the present study, we reported a new contrast injection-
protocol, which resulted in a 65% reduction of the extravasa-
tion rate as compared to the conventionally used three-phasic
CM injection-protocol in coronary CTA. The addition of a
Table 2 Comparison of the
extravasation rate, and clinical,
vein quality and image
acquisition characteristics
between the three-phasic contrast
media (CM) injection and four-
phasic CM injection-protocol
groups
Three-phasic group (n =
1,229)
Four-phasic group (n =
1,216)
p
Clinical characteristic
Age (y) 60.4 ± 12.1 60.8 ± 12.0 0.44
Female, n (%) 529 (44.1) 536 (43.0) 0.63
Height (cm) 171.2 ± 10.0 171.3 ± 10.2 0.88
Weight (kg) 83.8 ± 17.2 84.1 ± 17.2 0.62
BMI (kg/m2) 28.5 ± 4.9 28.6 ± 4.7 0.76
Hypertension, n (%) 816 (66.4) 789 (64.9) 0.44
Diabetes, n (%) 202 (16.4) 191 (15.7) 0.66
Dyslipidaemia, n (%) 582 (47.4) 560 (46.1) 0.54
AMI, n (%) 99 (8.1) 86 (7.1) 0.36
PAD, n (%) 120 (10.6) 116 (10.1) 0.73
Stroke or TIA (%) 62 (5.0) 73 (6.0) 0.33
Smoking (%) 497 (40.5) 493 (40.4) 0.97
Vein quality characteristics
Venous access side (right %) 1,103 (89.7) 1,066 (87.7) 0.11
Cubital cannula (%) 1,163 (94.6) 1,130 (92.9) 0.09
Cannula size
18 G, n (%) 1,195 (97.2) 1,178 (96.9) 0.63
20 G, n (%) 34 (3.1) 38 (3.1) 0.63
Cannula size (18 G%) 1,195 (97.2) 1,178 (96.9) 0.63
Successful cannula insertion at first
attempt (%)
1,124 (91.5) 1,122 (92.7) 0.77
Contrast material characteristics
Contrast material volume 91.3 ± 7.3 91.0 ± 7.4 0.23
Injection flow rate
5.5 ml/s, n (%) 1,121 (91.2) 1,075 (88.4) 0.02
AMI acute myocardial infarction, BMI body mass index, PAD peripheral artery disease, TIA transient ischaemic
attack, DLP dose-length product
Fig. 2 The contrast media extravasation rate in the three-phasic group
was 1.4% (17/1,229), whereas in the four-phasic contrast media injection-
protocol group the extravasation rate was 0.5% (6/1,216), p = 0.034
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saline pacer bolus to the three-phasic CM injection-protocol is
easy to implement at no additional cost.
We found an overall extravasation rate of 0.9%, which is
similar to that in the published literature (0.3–1.3%) [1–5].
Interestingly, from the comprehensive review of Cohan et al.
published in 1996 [2] through recent publications, the same
range of extravasation rate is reported, which suggests that no
effective strategy is available to reduce the risk of CM extrav-
asation [1–5]. To the best of our knowledge our study is the
first to describe the four-phasic CM injection-protocol, in
which a saline pacer bolus is added to the conventional
three-phasic CM protocol to reduce the risk of extravasation.
We detected a statistically significant difference between
the three- and four-phasic group regarding contrast injection
rates (5.5 ml/s: 91.2% (1,121/1,229) vs. 88.4% (1,075/1,216),
respectively, p = 0.02); however, we did not find any differ-
ence in injection flow rates among patients with versus with-
out extravasation (5.5 ml/s flow rate: 95.7% (22/23) vs. 89.8%
(2,174/2,422), respectively, p = 0.72). In a study by Federle
et al., the effect of contrast bolus flow rate was evaluated in
5,106 patients who received CM for CTA examination, and
they detected no correlation between extravasation and injec-
tion flow rate [3]. The mean CM injection flow rate was
2.8 ml/s (range 1–5 ml/s) and they observed an overall extrav-
asation in 0.9% of the scans. Although the authors used low
flow rates, they still experienced the same percentage of ex-
travasation independent of the injection speed as we did in our
study. This suggests that instead of the flow rate other charac-
teristics, such as CM viscosity and collapsed vein wall, might
play a role in extravasation. We adjusted the CM injection
rates according the tube voltage setting. In case of 120 kV
we used a higher injection rate (5.5 ml/s) in order to achieve
higher intracoronary attenuation. In case of 100 kV we used
lower injection rates (4.5 ml/s), due to the increased iodine x-
ray absorption at lower tube voltages.
Davenport et al. assessed whether extrinsic warming of
low- and high-osmolality CM affects the extravasation rate
[15]. They could not detect any beneficial effect of preheating
on low-osmolality CM extravasation rates (preheated: 0.30%
(32/10,831), non-heated: 0.23% (23/10,064); p = 0.64); how-
ever, pre-heating of high-osmolality CM decreased extravasa-
tion rate as compared to non-heated (0.27% (5/1,851) vs.
0.87% (18/2,074), respectively; p = 0.05. Similar to these
findings, in a prospective study of 4,457 patients iodine con-
centration and flow rate did not show any association with
CM extravasation [4]. In these studies, besides the injection
flow rate, the CM injection-protocol was not described in
detail, rendering direct comparisons with our study difficult.
Other studies have identified several risk factors of CM
extravasation that are unrelated to CM administration proto-
cols and are not modifiable. These risk factors are mainly
associated with the fragility of the patients’ vasculature, such
as atherosclerosis, diabetes, chemo- or radiotherapy, and
autoimmune diseases [2, 12]. Female gender and elderly age
(>60 years) were predictors of CM extravasation in a study by
Shaquan et al. [11]. Our results suggest that four-phasic pro-
tocol reduces extravasation rate independently of these risk
factors.
CM extravasation may cause severe complications due to
the toxic effects of iodinated CM on the perivascular tissues
[2, 5]. Furthermore, it may lead to repeated CTA exams with a
consequently higher radiation dose, increased CM load and
higher costs. Therefore, the reduction of CM extravasation is
of importance. It seems that the beneficial effect of a four-
phasic CM injection-protocol is due to the saline pacer bolus,
which opens the vein before the high flow-rate CM injection
and reduces the risk of vessel wall injury and extravasation,
and reduces the risk of vessel wall injury and extravasation.
Some state-of-the art power injectors offer ‘keep vein open’
functionality with an intravenous saline drip that is flowing
just enough (e.g. 0.25 ml every 30 s) to keep the vein open for
a longer time period and prevent coagulation or clot formation
at the injection site. Intuitively, this technique might also re-
duce the risk of extravasation to some extent. However, it is
unlikely that the slow drip of saline prevents extravasation as
effectively as the saline pacer bolus described in our study,
although this needs further investigation. Furthermore, it is
important to note that the four-phasic CM injection-protocol
is vendor independent and can be programmed with all power
injectors.
It is important to note that with the introduction of novel
CT technologies, the amount of CM needed to achieve diag-
nostic quality has markedly decreased. In a recently published
study by Kim et al., CM volume usage in coronary CTA
performed with 320-row CT could be decreased from 60 to
40 ml with preserved image quality and diagnostic accuracy
[16]. In addition, Felmly et al. demonstrated that with the
latest generation dual source CT a comprehensive transcathe-
ter aortic valve replacement planning was feasible with re-
duced CM volumes [17]. In line with these findings,
Mangold et al. demonstrated that the use of automated tube
voltage selection and CM volume adjustment reduces CM
volumes and provides excellent image quality and optimal
intravascular attenuation [18]. The effect of novel CT technol-
ogies and reduced CM volumes on extravasation rate warrants
further investigation.
Our study has some limitations, which should be acknowl-
edged. First, this was a single-centre study, which might limit
the generalizability of our results. We used a deterministic
method for randomization, which involves open allocation
based on odd and even weeks. This might potentially influ-
ence recruitment. However, in our study we enrolled all eligi-
ble patients, therefore the risk of selection bias is minimized.
In addition, we did not perform a power calculation. However,
during the 20-month study period we enrolled the maximum
number of patients. Furthermore, we defined extravasation
4542 Eur Radiol (2017) 27:4538–4543
based on local symptoms and the inadequate CM enhance-
ment in CTA images. To further objectivize extravasation
events a dedicated extravasation monitor system or pressure
monitoring would have been beneficial; however, at the time
of the study this was not available at our site.
In conclusion, the implementation of four-phasic CM
injection-protocol in routine coronary CTA practice is easy
and reduces the risk of extravasation at no extra cost. The
addition of a saline pacer bolus might be beneficial for all
CM injection-protocols in general CT angiography as well;
however, this warrants further investigations.
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